These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
238 related items for PubMed ID: 19878060
21. Critical parameters for the isolation of mesenchymal stem cells from umbilical cord blood. Bieback K, Kern S, Klüter H, Eichler H. Stem Cells; 2004; 22(4):625-34. PubMed ID: 15277708 [Abstract] [Full Text] [Related]
22. Isolation of human mesenchymal stromal cells is more efficient by red blood cell lysis. Horn P, Bork S, Diehlmann A, Walenda T, Eckstein V, Ho AD, Wagner W. Cytotherapy; 2008; 10(7):676-85. PubMed ID: 18985474 [Abstract] [Full Text] [Related]
23. Umbilical cord mesenchymal stem cells: adjuvants for human cell transplantation. Friedman R, Betancur M, Boissel L, Tuncer H, Cetrulo C, Klingemann H. Biol Blood Marrow Transplant; 2007 Dec; 13(12):1477-86. PubMed ID: 18022578 [Abstract] [Full Text] [Related]
26. Isolation of mesenchymal stem cells using the total length of umbilical cord for transplantation purposes. Tsagias N, Koliakos I, Karagiannis V, Eleftheriadou M, Koliakos GG. Transfus Med; 2011 Aug; 21(4):253-61. PubMed ID: 21623971 [Abstract] [Full Text] [Related]
27. UC blood-derived mesenchymal stromal cells: an overview. Flynn A, Barry F, O'Brien T. Cytotherapy; 2007 Aug; 9(8):717-26. PubMed ID: 17917891 [Abstract] [Full Text] [Related]
28. Animal serum-free culture conditions for isolation and expansion of multipotent mesenchymal stromal cells from human BM. Müller I, Kordowich S, Holzwarth C, Spano C, Isensee G, Staiber A, Viebahn S, Gieseke F, Langer H, Gawaz MP, Horwitz EM, Conte P, Handgretinger R, Dominici M. Cytotherapy; 2006 Aug; 8(5):437-44. PubMed ID: 17050248 [Abstract] [Full Text] [Related]
30. Fetal mesenchymal stem cells derived from human umbilical cord sustain primitive characteristics during extensive expansion. Jo CH, Kim OS, Park EY, Kim BJ, Lee JH, Kang SB, Lee JH, Han HS, Rhee SH, Yoon KS. Cell Tissue Res; 2008 Dec; 334(3):423-33. PubMed ID: 18941782 [Abstract] [Full Text] [Related]
31. Immunosuppressive properties of mesenchymal stromal cells derived from amnion, placenta, Wharton's jelly and umbilical cord. Manochantr S, U-pratya Y, Kheolamai P, Rojphisan S, Chayosumrit M, Tantrawatpan C, Supokawej A, Issaragrisil S. Intern Med J; 2013 Apr; 43(4):430-9. PubMed ID: 23176558 [Abstract] [Full Text] [Related]
32. Human mesenchymal stem cells from the umbilical cord matrix: successful isolation and ex vivo expansion using serum-/xeno-free culture media. Simões IN, Boura JS, dos Santos F, Andrade PZ, Cardoso CM, Gimble JM, da Silva CL, Cabral JM. Biotechnol J; 2013 Apr; 8(4):448-58. PubMed ID: 23420807 [Abstract] [Full Text] [Related]
33. Umbilical cord tissue-derived mesenchymal stem cells grow best under GMP-compliant culture conditions and maintain their phenotypic and functional properties. Hartmann I, Hollweck T, Haffner S, Krebs M, Meiser B, Reichart B, Eissner G. J Immunol Methods; 2010 Dec 15; 363(1):80-9. PubMed ID: 21035451 [Abstract] [Full Text] [Related]
35. Human alternatives to fetal bovine serum for the expansion of mesenchymal stromal cells from bone marrow. Bieback K, Hecker A, Kocaömer A, Lannert H, Schallmoser K, Strunk D, Klüter H. Stem Cells; 2009 Sep 15; 27(9):2331-41. PubMed ID: 19544413 [Abstract] [Full Text] [Related]
37. CD105(+) cells from Wharton's jelly show in vitro and in vivo myogenic differentiative potential. Conconi MT, Burra P, Di Liddo R, Calore C, Turetta M, Bellini S, Bo P, Nussdorfer GG, Parnigotto PP. Int J Mol Med; 2006 Dec 15; 18(6):1089-96. PubMed ID: 17089012 [Abstract] [Full Text] [Related]